sb 203580 has been researched along with Viral Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bharate, SB; Raghuvanshi, R | 1 |
| Caballero, E; García-Cárceles, J; Gil, C; Martínez, A | 1 |
| Adner, M; Benson, M; Björnsson, S; Cardell, LO; Fransson, M; Månsson, A; Uddman, R | 1 |
1 review(s) available for sb 203580 and Viral Diseases
| Article | Year |
|---|---|
Kinase Inhibitors as Underexplored Antiviral Agents.
Topics: Animals; Antiviral Agents; Drug Repositioning; Humans; Protein Kinase Inhibitors; Virus Diseases; Viruses | 2022 |
2 other study(ies) available for sb 203580 and Viral Diseases
| Article | Year |
|---|---|
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; High-Throughput Screening Assays; Humans; Protein Kinase Inhibitors; SARS-CoV-2; United States; United States Food and Drug Administration; Virus Diseases | 2022 |
TLR3 in human eosinophils: functional effects and decreased expression during allergic rhinitis.
Topics: Adult; Blood Cell Count; Bone Marrow Cells; CD11b Antigen; Cell Count; Cysteine Proteinase Inhibitors; Eosinophils; Female; Gene Expression; Humans; Imidazoles; Interleukin-4; Interleukin-5; Interleukin-8; Leupeptins; Male; Middle Aged; Neutrophils; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Poly I-C; Protein Kinase Inhibitors; Pyridines; Rhinitis, Allergic, Seasonal; Signal Transduction; Toll-Like Receptor 3; Virus Diseases; Young Adult | 2010 |